Transforming growth factor: β signaling is essential for limb regeneration in axolotls

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Lévesque, Mathieu ^a   Gatien, Samuel ^a   Finnson, Kenneth ^b   Desmeules, Sophie ^a   Villiard, Éric ^a   Pilote, Mireille ^a   Philip, Anie ^b   Roy, Stéphane ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; COMPLEMENTARY DNA; TRANSFORMING GROWTH FACTOR BETA; 1,3 DIOXOLANE DERIVATIVE; 4 (5 BENZO(1,3)DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; BENZAMIDE DERIVATIVE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

AMBYSTOMA; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; LIMB REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; WOUND HEALING; AMBYSTOMA MEXICANUM; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LIMB; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; REGENERATION; SEQUENCE HOMOLOGY;

AMBYSTOMA MEXICANUM; AMPHIBIA; MAMMALIA; VERTEBRATA;

AMBYSTOMA MEXICANUM; AMINO ACID SEQUENCE; ANIMALS; BENZAMIDES; CELL PROLIFERATION; CLONING, MOLECULAR; DIOXOLES; DNA, COMPLEMENTARY; EXTREMITIES; MOLECULAR SEQUENCE DATA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REGENERATION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 41149097772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001227     Document Type: Article

References (95)

1. Wallace H (1981) Vertebrate limb regeneration. Chichester Eng.; New York: Wiley. pp xii, 276.
2. Roy S, Levesque M (2006) Limb regeneration in axolotl: is it superhealing? ScientificWorldJournal 6: 12-25.
3. Tsonis PA (1996) Limb regeneration. Cambridge [England]; New York, NY, USA: Cambridge University Press. pp xii, 241.
4. Goss RJ (1980) Prospects of regeneration in man. Clin Orthop Relat Res. pp 270-282.
5. Martin P (1997) Wound healing aiming for perfect skin regeneration. Science 276: 75-81.
6. Harty M, Neff AW, King MW, Mescher AL (2003) Regeneration or scarring: an immunolugic perspective. Dev Dyn 226: 268-279.
7. Gardiner DM, Blumberg B, Komine Y, Bryant SV (1995) Regulation of HoxA expression in developing and regenerating axolotl limbs. Development 121: 1734-1741.
8. Gardiner DM, Carlson MR, Roy S (1999) Towards a functional analysis of limb regeneration. Semin Cell Dev Biol 10: 385-393.
9. Mescher AL, Neff AW (2006) Limb regeneration in amphibians: immunological considerations. ScientificWorldJournal 6: 1-11.
10. Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, et al. (2005) Limb regeneration in higher vertebrates: developing a roadmap, Anat Rec B New Anat 287: 14-24.
11. Singer M, Salpeter AM (1961) Regeneration in vertebrates: The role of the wound epithelium. In: Zarrow MX, ed. Growth in Living System. New York: Basic Books. pp 277-311.
12. Chodorowska G, Rogus-Skorupska D (2004) Cutaneous wound healing. Ann Univ Mariae Curie Sklodowska [Med] 59: 403-407.
13. Clark RA (1985) Cutaneous tissue repair: basic biologic considerations. I. J Am Acad Dermatol 13: 701-725.
14. Carlson MR, Bryant SV, Gardiner DM (1998) Expression of Msx-2 during development, regeneration, and wound healing in axolotl limbs. J Exp Zool 282; 715-723.
15. Christensen RN, Tassava RA (2000) Apical epithelial cap morphology and fibronectin gene expression in regenerating axolotl limbs. Dev Dyn 217: 216-224.
16. Mullen LM, Bryant SV, Torok MA, Blumberg B, Gardiner DM (1996) Nerve dependency of regeneration: the role of Distal-less and FGF signaling in amphibian limb regeneration. Development 122: 3487-3497.
17. Vinarsky V, Atkinson DL, Stevenson TJ, Keating MT, Odelberg SJ (2005) Normal newt limb regeneration requires matrix metalloproteinase function. Dev Biol 279: 86-98.
18. Yang EV, Bryant SV (1994) Developmental regulation of a matrix metalloproteinase during regeneration of axolotl appendages. Dev Biol 166: 696-703.
19. Yang EV, Gardiner DM, Carlson MR, Nugas CA, Bryant SV (1999) Expression of Mmp-9 and related matrix metalloproteinase genes during axolotl limb regeneration. Dev Dyn 216: 2-9.
20. Kahari VM, Saarialho-Kere U (1997) Matrix metalloproteinases in skin. Exp Dermatol 6: 199-213.
21. Madlener M (1998) Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds. Arch Dermatol Res 290 Suppl: S24-29.
22. Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647.
23. Burt DW, Law AS (1994) Evolution of the transforming growth factor-beta superfamily. Prog Growth Factor Res 5: 99-118.
24. Massague J, Blain SW, Lo RS (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
25. Prud'homme GJ, Piccirillo CA (2000) The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 14: 23-42.
26. Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16: 137-161.
27. O'Kane S, Ferguson MW (1997) Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 29: 63-78.
28. Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. Faseb J 18: 816-827.
29. Huang SS, Huang JS (2005) TGF-beta control of cell proliferation. J Cell Biochem, 96: 447-462.
30. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165: 251-256.
31. Pierce GF, Mustoe TA, Deuel TF (1988) Transforming growth factor beta induces increased directed cellular migration and tissue repair in rats. Prog Clin Biol Res 266: 93-102.
32. Gailit J, Welch MP, Clark RA (1994) TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 103: 221-227.
33. Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC (1991) Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol 148: 157-173.
34. Chalkley DT (1954) A quantitative histological analysis of forelimb regeneration in Triturus viridesceas. J Morphol 94: 21-70.
35. Muneoka K, Fox WF, Bryant SV (1986) Cellular contribution from dermis and cartilage to the regenerating limb blastema in axolotls. Dev Biol 116: 256-260.
36. Endo T, Bryant SV, Gardiner DM (2004) A stepwise model system for limb regeneration. Dev Biol 270: 135-145.
37. Cash DE, Gates PB, Imokawa Y, Brockes JP (1998) Identification of newt connective tissue growth factor as a target of retinoid regulation in limb blastemal cells. Gene 222: 119-124.
38. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, et al. (2002) Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). J Med Chem 45: 999-1001.
39. Bayliss PE, Bellavance KL, Whitehead GG, Abrams JM, Aegerter S, et al. (2006) Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish. Nat Chem Biol 2: 265-273.
40. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.
41. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, et al. (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64.
42. Liu XJ, Ruan CM, Gong XF, Li XZ, Wang HL, et al. (2005) Antagonism of transforming growth factor-Beta signaling inhibits fibrosis-related genes. Biotechnol Lett 27: 1609-1615.
43. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, et al. (2004) Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 50: 4008-4021.
44. Wu S, Peng J, Duncan MR, Kasisomayajula K, Grotendorst G, et al. (2007) ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung. Am J Respir Cell Mol Biol 36: 552-561.
45. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292.
46. Letterio JJ, Roberts AB (1996) Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J Leukoc Biol 59: 769-774.
47. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J Cell Sci 116: 217-224.
48. Janssens K, ten Dijke P, Janssens S, Van Hul W (2005) Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-774.
49. Roy S, Gardiner DM, Bryant SV (2000) Vaccinia as a tool for functional analysis in regenerating limbs: ectopic expression of Shh. Dev Biol 218: 199-205.
50. Tam BY, Finnson KW, Philip A (2003) Glycosylphosphatidylinositol-anchored proteins regulate transforming growth factor-beta signaling in human keratinocytes. J Biol Chem 278: 49610-49617.
51. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
52. Piek E, Franzen P, Heldin CH, ten Dijke P (1997) Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. J Cell Physiol 173: 447-459.
53. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, et al. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67: 785-795.
54. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, et al. (1991) Expression cloning and characterization of the TGF-beta type III receptor. Cell 67: 797-805.
55. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ (2004) Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol 165: 741-751.
56. Quan T, He T, Voorhees JJ, Fisher GJ (2001) Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 276: 26349-26356.
57. Putta S, Smith JJ, Walker JA, Rondet M, Weisrock DW, et al. (2004) From biomedicine to natural history research: EST resources for ambystomatid salamanders. BMC Genomics 5: 54.
58. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, et al. (1988) Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung Fibroblasts and carcinoma cells. J Biol Chem 263: 3111-3115.
59. Quart G, Choi JY, Lee DS, Lee SC (2005) TGF-beta1 up-regulates transglutaminase two and fibronectin in dermal fibroblasts: a possible mechanism for the stabilization of tissue inflammation. Arch Dermatol Res 297: 84-90.
60. Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P. et al. (2006) Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. Faseb J 20: 1525-1527.
61. Sun Z, Jin P, Tian T, Gu Y, Chen YG, et al. (2006) Activation and roles of ALK4/ALK7-mediated maternal TGFbeta signals in zebrafish embryo. Biochem Biophys Res Commun 345: 694-703.
62. Ho DM, Chan J, Bayliss P, Whitman M (2006) Inhibitor-resistant type I receptors reveal specific requirements for TGF-beta signaling in vivo. Dev Biol 295: 730-742.
63. James D, Levine AJ, Besser D, Hemmati-Brivandou A (2005) TGFbeta/activin/ nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282.
64. Tank PW, Carlson BM, Connelly TG (1976) A staging system for forelimb regeneration in the axolot1, Ambystoma mexicanum. J Morphol 150: 117-126.
65. Hutchison C, Pilote M, Roy S (2007) The axolot1 limb: a model for bone development, regeneration and fracture healing. Bone 40: 45-56.
66. Shah M, Foreman DM, Ferguson MW (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339: 213-214.
67. Shah M, Foreman DM, Ferguson MW (1994) Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107: 1137-1157.
68. Shah M, Forrman DM, Ferguson MW (1995) Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 108: 985-1002.
69. Frank S, Madlener M, Werner S (1996) Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 271: 10188-10193.
70. Martin P, Dickson MC, Millan FA, Akhurst RJ (1993) Rapid induction and clearance of TGF beta 1 is an early response to wounding in the mouse embryo. Dev Genet 14: 225-238.
71. Grose R, Martin P (1999) Parallels between wound repair and morphogenesis in the embryo. Semin Cell Dev Biol 10: 395-404.
72. Ferguson MW, O'Kane S (2004) Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 359: 839-850.
73. Wang XJ, Han G, Owens P, Siddiqui Y, Li AG (2006) Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc 11: 112-117.
74. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, et al. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 84: 5788-5792.
75. Kaufman J, Volk H, Wallny HJ (1995) A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism. Immunol Rev 143: 63-88.
76. Tournefier A, Laurens V, Chapusot C, Ducoroy P, Padros MR, et al. (1998) Structure of MHC class I and class II cDNAs and possible immunodeficiency linked to class II expression in the Mexican axolot1. Immunol Rev 166: 259-277.
77. Sicard RE (1985) Regulation of vertebrate limb regeneration. New York: Oxford University Press. pp, ix, 185.
78. Montesano R, Carrozzino F, Soulie P (2007) Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells. BMC Dev Biol 7: 7.
79. Ninomiya K, Takahashi A, Fujioka Y, Ishikawa Y, Yokoyama M (2006) Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells. Hypertens Res 29: 269-276.
80. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
81. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
82. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, et al. (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
83. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. Embo J 23: 552-563.
84. Roberts AB (1995) Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound rep reg 3: 408-418.
85. Chang J, Thunder R, Most D, Longaker MT, Lineaweaver WC (2000) Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg 105: 148-155.
86. Jester JV, Barry-Lane PA, Petroll WM, Olsen DR, Cavanagh HD (1997) Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea 16: 177-187.
87. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, et al. (2005) The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201: 391-397.
88. Nath RK, Kwon B, Mackinnon SE, Jensen JN, Reznik S, et al. (1998) Antibody to transforming growth factor beta reduces collagen production in injured peripheral nerve. Plast Rcoonstr Surg 102: 1100-1106; discussion 1107-1108.
89. Schultze-Mosgau S, Wehrhan F, Rodel F, Amann K, Radespiel-Troger M, et al. (2004) And-TGFbeta1 antibody for modulation of expression of endogenous transforming growth factor beta 1 to prevent fibrosis after plastic surgery in rats. Br J Oral Maxillofac Surg 42: 112-119.
90. Jawinska A, Badakov R, Keating MT (2007) Activin-beta-A Signaling Is Required for Zebrafish Fin Regeneration. Curr Biol 17: 1390-1395.
91. Levesque M, Guimond JC, Pilote M, Leclerc S, Moldovan F, et al. (2005) Expression of heat-shock protein 70 during limb development and regeneration in the axolot1. Dev Dyn 233: 1525-1534.
92. Iten LE, Bryant SV (1973) Forelimb regeneration from different levels of amputation in the Newt, Notophthalmus virisdescens: Lenght, Rate, and Stages. Wilhelm Roux' Archiv 173: 263-282.
93. Roy S, Martel J, Ma S, Tenenhouse HS (1994) Increased renal 25-hydroxyvitamin D3-24-hydroxylase messenger ribonucleic acid and immunoreactive protein in phosphate-deprived Hyp mice: a mechanism for accelerated 1,25-dihydroxyvitamin D3 catabolism in X-linked hypophosphatemic rickets. Endocrinology 134: 1761-1767.
94. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
95. Luna LG, Armed Forces Institute of Pathology (U.S.), Armed Forces Institute of Pathology (U.S.) (1968) Manual of histologic staining methods of the Armed Forces InstitLte of Pathology. New York,: Blakiston Division. pp xii, 258.